Half of patients with the most severe brain metastases may not be receiving palliative care consultations.Those who do have a ...
Patients with up to 20 brain metastases demonstrated significantly improved daily and neurocognitive functioning with ...
A new study from researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain ...
Brain metastases arising from gynecologic cancers, including ovarian, endometrial and cervical malignancies, present unique diagnostic and therapeutic challenges. Although these metastatic events are ...
A team from the Spanish National Cancer Research Centre (CNIO) has discovered a novel way in which tumor cells alter the brain to establish themselves and spread cancer. They also demonstrate that a ...
InvestorsHub on MSN
Radiopharm reports 90% concordance in interim results for RAD 101 brain metastases trial
Radiopharm Theranostics (NASDAQ:RADX) announced interim findings from its Phase 2b clinical trial evaluating RAD 101, an imaging agent designed to detect recurrent brain metastases, according to a ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced the addition of two new Caris AI Insightsâ„¢ signatures ...
RAD 101 and evaluable at interim analysis achieved concordance with MRI imaging (the primary endpoint) First five patients with available data from six-month follow-up and biopsy show encouraging ...
Hosted on MSN
Blood biomarker points to increased risk of brain metastasis in patients with inflammatory breast cancer
Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a ...
CNS metastases in EGFR-mutant NSCLC are prevalent and worsen prognosis, especially with acquired progression during treatment. Amivantamab plus lazertinib shows promising CNS activity, but current ...
In a remarkable case of precision oncology and multidisciplinary care, a 45-Year-Old Male diagnosed with advanced Lung Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results